NCT04942301 2021-06-30PK Study for Endostar Continuous Intravenous Infusion in NSCLC Patients With 1st-line Platinum Based ChemotherapyJiangsu Simcere Pharmaceutical Co., Ltd.Phase 1 Unknown24 enrolled